Available Cornell Technologies
- Reactive Ion Etching of Barium Stannate
- CDCP1 as a Novel Therapeutic Target for Cancer Therapy
- Local and Continuous Delivery of a Mast Cell Stabilizer During Wound Healing to Reduce Fibrotic Scarring
- Single Sperm Sequencing Assay for Prediction of Autism Risk and as a Substitute for Manual Sperm Analysis
- Pumpless, Unidirectional, and Multiorgan Microfluidic Platform for Preclinical Drug Testing
- Ultra-sensitive Detection of Circulating Tumor DNA through Genome-wide Integration
Licensing
CTL is industry's link to Cornell's broad range of innovative research that is available for licensing. Over the years, Cornell technologies have been licensed to industry partners all over the world. In support of Cornell's land-grant mission and to develop these technologies and plant varieties into products and services for public good.
Tweets by @Cornell_CTL
Like CTL on Facebook
Like CTL on Facebook for a timeline of updates about Cornell Startups and products based on licensed Cornell technologies.
Plant Varieties at Cornell
|
|